Recruiting

GMVs

Sponsor:

Université de Sherbrooke

Code:

NCT07543718

Conditions

Dyslipidemias

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Group medical visits

Study Details

Brief summary:

Physicians' interventions to promote the improvement of lifestyle habits have been shown to be effective. However, such interventions remain underutilized due to barriers such as lack of time, confidence, and compensation. Group medical visits (GMVs) can help overcome several of these barriers and effectively improve clinical indicators as well as patients' quality of life. GMVs could also reduce pressure on the healthcare system by improving access to primary care through a more efficient use of resources. The literature suggests that GMVs can be effective in improving access to care and reducing disease complications for patients with several conditions and risk factors, but they have not been assessed specifically among patients with dyslipidemia, which is at the origin of most cases of cardiovascular diseases. In this context, GMVs will be implemented among 144 patients with dyslipidemia. The objective for this project is to evaluate implementation of GMVs. The implementation evaluation will follow the RE-AIM framework. These steps will position the research team to develop more complex and large-scale studies in lifestyle medicine. In the meantime, the project will contribute to improve access to primary care for the prevention of cardiovascular diseases.

Conditions

Dyslipidemias

Study ID

NCT07543718

Start date

Apr, 2026

Status verified date

Mar, 2026

Completion date

Dec, 2030

Anticipated

Primary completion date

Jan, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Diagnosis of dyslipidemia according to the guidelines of the Canadian Cardiovascular Society, i.e., at a minimum: an intermediate cardiovascular risk according to the Framingham Risk Score (10-19.9%) WITH LDL-C ≥ 3.5 mmol/L or non-HDL-C ≥ 4.2 mmol/L or ApoB ≥ 1.05 g/L

Exclusion Criteria:

  • Patients unable to participate in GMV sessions or to provide informed consent

  • Patients with a mental health condition likely to limit their ability to benefit from GMV sessions and discussions (Examples: severe dementia or an acute psychiatric decompensation occurring within the past six months)
  • A diagnosis of terminal illness or a life expectancy of less than 12 months

Study Design

Enrollment

288 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: Intervention group

The intervention consists of regular care supplemented by a series of group medical visits (GMVs). Each series of GMVs will last 9-12 months and will include eight sessions of 90-120 minutes covering topics related to lifestyle medicine within the context of dyslipidemia management. These sessions will be offered to groups of 8 to 12 patients and delivered by a mix of family physicians, dietitians, kinesiologists, and psychologists, all trained to deliver GMVs. Each session will begin with a revision of the goals established in the previous session, followed by a didactic component including demonstrations, questioning, and experiential activities. Emphasis will be placed on health self management and on developing realistic, specific, and observable personal goals. The sessions will include opportunities for social interaction among participants and will offer opportunities for brief one on one consultations patients and health professionals if needed.

no intervention: Usual care group

Participants in the usual-care group will have access to their regular follow-up with their primary care providers. They will also have the option to take part in the GMVs after the project's final evaluation period.

Interventions

Group medical visits

Group medical visits are designed to improve knowledge of participants and promote self-management.

Primary outcome measure

  • Lipid profile [ Time Frame: 12 months ]

Central Contacts and Locations

Central contacts

Mathieu Belanger, PhD

5068632221mathieu.f.belanger@usherbrooke.ca

Locations

Unité de médecine familiale du Grand-Moncton

Recruiting

Dieppe, New Brunswick, Canada, E1A1G6

Contacts

Mathieu Belanger, PhD

5068632221mathieu.f.belanger@usherbrooke.ca

More Information

Sponsor

Université de Sherbrooke

Last update posted

Apr 22, 2026

Last verified

Mar, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Université de Sherbrooke on 2026-04-22.